Unicycive Therapeutics, Inc.
UNCY
$4.44
-$0.31-6.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.50M | -15.20M | -36.73M | -23.00M | -23.24M |
| Total Depreciation and Amortization | 530.00K | 279.00K | 428.00K | 376.00K | 332.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.40M | -11.96M | 8.15M | -2.83M | -2.15M |
| Change in Net Operating Assets | -6.56M | -4.14M | -427.00K | -1.01M | 3.42M |
| Cash from Operations | -33.12M | -31.02M | -28.58M | -26.47M | -21.64M |
| Capital Expenditure | -68.00K | -82.00K | -72.00K | -50.00K | -26.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -68.00K | -82.00K | -72.00K | -50.00K | -26.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.80M | 3.47M | 683.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 50.00M | 50.00M | 50.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -1.10M | -1.10M | -1.10M | -1.10M |
| Other Financing Activities | -1.07M | -435.00K | -4.50M | -4.39M | -4.28M |
| Cash from Financing | 13.74M | 1.94M | 45.09M | 44.52M | 44.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.45M | -29.16M | 16.44M | 18.00M | 22.96M |